Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

What we know so far: COVID-19 current clinical knowledge and research

What we know so far: COVID-19 current clinical knowledge and research REVIEW Clinical Medicine 2020 Vol 20, No 2: 124–7 ORIGINAL RESEARCH Clinical Medicine 2017 Vol 17, No 6: 124–8 What we know so far: COVID-19 current clinical knowledge and research Author: Mary A Lake In December 2019, health authorities in Wuhan, China, SARS-CoV-2 identifi ed a cluster of pneumonia cases of unknown aetiology The clinical disease termed COVID-19 is caused by a novel linked to the city’s South China Seafood Market. Subsequent betacoronavirus, now named SARS-CoV-2. SARS-CoV-2 shares investigations revealed a novel coronavirus, SARS-CoV-2, as 79% sequence identity with SARS-CoV, the virus which caused the causative agent now at the heart of a major outbreak. 2–4 a major outbreak in 2002–2003. In common with SARS-CoV, The rising case numbers have been accompanied by SARS-CoV-2 utilises the ACE-2 receptor for cell entry. Electron unprecedented public health action, including the wholesale microscopy reveals pleomorphic spherical particles, studded isolation of Wuhan. Alongside this has been a robust scientifi c with distinctive spike proteins. Coronaviruses, a family which response, including early publication of the pathogen also includes Middle East respiratory syndrome (MERS) CoV genome, and rapid development of highly specifi c diagnostics. and four of the main agents of the common cold, are http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Medicine Unpaywall

What we know so far: COVID-19 current clinical knowledge and research

Clinical MedicineMar 1, 2020
4 pages

Loading next page...
 
/lp/unpaywall/what-we-know-so-far-covid-19-current-clinical-knowledge-and-research-s0p4eM5p0Q

References (29)

Publisher
Unpaywall
ISSN
1470-2118
DOI
10.7861/clinmed.2019-coron
Publisher site
See Article on Publisher Site

Abstract

REVIEW Clinical Medicine 2020 Vol 20, No 2: 124–7 ORIGINAL RESEARCH Clinical Medicine 2017 Vol 17, No 6: 124–8 What we know so far: COVID-19 current clinical knowledge and research Author: Mary A Lake In December 2019, health authorities in Wuhan, China, SARS-CoV-2 identifi ed a cluster of pneumonia cases of unknown aetiology The clinical disease termed COVID-19 is caused by a novel linked to the city’s South China Seafood Market. Subsequent betacoronavirus, now named SARS-CoV-2. SARS-CoV-2 shares investigations revealed a novel coronavirus, SARS-CoV-2, as 79% sequence identity with SARS-CoV, the virus which caused the causative agent now at the heart of a major outbreak. 2–4 a major outbreak in 2002–2003. In common with SARS-CoV, The rising case numbers have been accompanied by SARS-CoV-2 utilises the ACE-2 receptor for cell entry. Electron unprecedented public health action, including the wholesale microscopy reveals pleomorphic spherical particles, studded isolation of Wuhan. Alongside this has been a robust scientifi c with distinctive spike proteins. Coronaviruses, a family which response, including early publication of the pathogen also includes Middle East respiratory syndrome (MERS) CoV genome, and rapid development of highly specifi c diagnostics. and four of the main agents of the common cold, are

Journal

Clinical MedicineUnpaywall

Published: Mar 1, 2020

There are no references for this article.